Latest Observability News

Page 28 of 85
Sky Metals has reported upgraded assay results from its Tallebung Tin Project in NSW, revealing multiple new shallow, high-grade tin and silver mineralisation zones. A major drilling campaign of over 100 holes is poised to begin imminently, aiming to expand and upgrade the resource.
Maxwell Dee
Maxwell Dee
30 Sept 2025
Newmont Corporation announces the retirement of CEO Tom Palmer at year-end 2025, with President and COO Natascha Viljoen stepping up as the first female CEO in the company’s century-long history.
Maxwell Dee
Maxwell Dee
30 Sept 2025
Syntara Limited has reported encouraging Phase 2a results for amsulostat combined with ruxolitinib in treating myelofibrosis, demonstrating sustained symptom improvement and spleen volume reduction over 52 weeks.
Ada Torres
Ada Torres
30 Sept 2025
Somerset Minerals reports multiple wide zones of visible copper mineralisation from Phase-2 drilling at its Coppermine Project in Nunavut, Canada, with assays pending. The results extend known mineralisation over 150m below surface and set the stage for a major drilling scale-up.
Maxwell Dee
Maxwell Dee
30 Sept 2025
Athena Resources has reported outstanding assay and metallurgical results from its Byro South drilling program, revealing high-quality magnetite mineralisation with iron grades exceeding 68%. The company is now advancing towards a maiden resource estimate that could reshape the economics of its Byro Magnetite Project.
Maxwell Dee
Maxwell Dee
30 Sept 2025
Imagion Biosystems has completed the second tranche of its $3.5 million placement, raising $2.85 million to advance its proprietary MagSense® imaging technology targeting breast, prostate, and ovarian cancers.
Ada Torres
Ada Torres
29 Sept 2025
Nyrada Inc. has announced successful Phase I trial results for its lead drug candidate Xolatryp, confirming safety and pharmacokinetics that pave the way for a Phase IIa trial targeting heart attack patients next year.
Ada Torres
Ada Torres
29 Sept 2025
Chimeric Therapeutics reports encouraging early clinical trial outcomes for its CHM CDH17 CAR-T therapy, showing disease control and tumour shrinkage at higher dose levels with a strong safety profile.
Ada Torres
Ada Torres
29 Sept 2025
Dreadnought Resources has revealed a significant rare earth element discovery at its Stinger niobium deposit within the Gifford Creek Carbonatite, marking a new high-grade target in its Mangaroon Critical Metals project.
Maxwell Dee
Maxwell Dee
29 Sept 2025
Synlait has agreed to sell its North Island assets to global healthcare giant Abbott for approximately US$178 million, marking a strategic reset focused on debt reduction and operational simplification. The deal, expected to close by April 2026, positions Synlait to concentrate on its South Island operations and explore new growth avenues.
Victor Sage
Victor Sage
29 Sept 2025
Elanor Commercial Property Fund’s Independent Board Committee unanimously recommends rejecting Lederer’s unsolicited $0.70 per security takeover bid, supported by an Independent Expert’s report deeming the offer neither fair nor reasonable.
Eva Park
Eva Park
26 Sept 2025
Schaffer Corporation has pulled its first-half profit forecast for its Automotive Leather division following a major cyber-attack on Jaguar Land Rover that halted production. The incident casts uncertainty over short-term sales and profitability.
Victor Sage
Victor Sage
26 Sept 2025